xmlui.metadata.dc.relation.isbasedon | 1. Turner HH. A syndrome of infantilism, congenital webbed
neck, and cubitus valgus. Endocrinol. 1938; 23: 566-74.
2. Jones KL, Smith DW. Turner Syndrome. In: Smith’s recognizable
patterns of human malformation. Philadelphia:
Elsevier Sauders; 2006. p. 76-81.
3. Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH.
Prevalence, incidence, diagnostic delay, and mortality in
Turner syndrome. J Clin Endocrinol Metab. 2006; 91:
3897-902.
4. Gravholt CH, Juul S, Naeraa RW, Hansen J. Morbity in
Turner syndrome. J Clin Epidemiol. 1998; 51: 147-58.
5. Rosenfeld RG, Frane J, Attie KM, Brasel JA, Burstein S,
Cara JF, Chernausek S, Gotlin RW, Kuntze J, Lippe BM,
Mahoney PC, Moore VW, Saenger P, Johanson AJ. Six-year
results of a randomized, prospective trial of human growth
hormone and oxandrolone in Turner syndrome. J Pediatr
(Rio J). 1992; 121: 49-55
6. Davenport ML, Crowe BJ, Travers SH, Rubin K, Ross JL,
Fechner PY, Gunter DF, Liu C, Geffner M, Thrailkill K,
Huseman C, Zagar AJ, Quiqley C. Growth hormone treatment
of early growth failure in toddlers with Turner
Syndrome: a randomized, controlled, multicenter trial. J
Clin Endocrinol Metab. 2007; 92: 3406-16.
7. Hook EB, Warburton D. The distribution of chromosomal
genotypes associated with Turner's Syndrome: livebirth
prevalence rates and evidence for diminished fetal mortality
and severity in genotypes associated with structural X
abnormalities or mosaicism. Hum Genet. 1983; 64: 24-27.
8. Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF,
Jacobs PA. Cancer incidence in women with Turner
syndrome in Great Britain: a national cohort study. Lancet
Oncol. 2008; 9: 239-46.
9. El-Mansoury M, Barrenäs ML, Bryman I, Hanson C,
Larsson C, Wilhelmsen L, Landin-Wilhelmsen K.
Chromosomal mosaicism mitigates stigmata and cardiovascular
risk factors in Turner syndrome. Clin Endocrinol.
2007; 66: 744-51.
10. Hassold T, Benhaham F, Leppert M. Cytogenetics and
molecular analysis of sex chromosome monossomy. Am J
Hum Genet. 1988; 42: 534-41.
11. Araújo A, Ramos ES. Cryptic mosaicism involving a
second chromosome X in patients with Turner syndrome.
Braz J Med Biol Res. 2008; 41: 368-72.
12. Martins RRS, Ramos HIB, Llerena Jr. JC, Almeida JCC.
Investigação clínica e genética em meninas com baixa
estatura idiopática. Arq Bras Endocrinol Metab. 2003; 47:
684-94.
13. Berdahl LD, Wenstrom KD, Hanson JW. Web neck
anomaly and its association with congenital heart disease.
Am J Med Genet. 1995; 10; 56: 304-7.
14. Clement-Jones M, Schiller S, Rao E, Blaschke RJ, Zuniga
A, Zeller R, Robson SC, Binder G, Glass I, Strachan T,
Lindsey S, Rappold GA . The short stature homeobox gene
SHOX is involved in skeletal abnormalities in Turner
syndrome. Hum Mol Genet. 2000; 9: 695-702.
15. Kosho T, Muroya K, Nagai T, Fugimoto M, Yokoya S,
Sakamoto H, Hirano T, Terasaki H, Ohashi H, Nishimura G,
Sato S, Matsuo N, Ogata T. Skeletal features and growth
patterns in 14 patients with haploinsufficiency of SHOX:
Implications for the development of Turner syndrome. J
Clin Endocrinol Metab. 1999; 84: 4613-21.
16. Savendahl L, Davenport ML. Delayed diagnoses of
Turner´s syndrome: Proposed guidelines for change. J
Pediatr (Rio J). 2000; 137: 455-9. 17. Rappold GA, Blum WF, Shavrikova EP, Crowe BJ, Roeth
R, Quigley CA, Ross JL, Niesler B. Genotypes and phenotypes
in children with short stature: clinical indicators of
SHOX haploinsufficiency. J Med Genet. 2007; 44: 306-13.
18. Massa G, Verlinde F, De Shepper J, Thomas M, Bourgignon
JP, Craen M, de Zegher F, Francois I, Du Caju M, Maes M,
Heinrichs C, The Belgian Study Group for Paediatric
Endocrinology. Trends in age at diagnosis of Turner
syndrome. Arch Dis Child. 2005; 90: 267-8.
19. Massa GG, Vanderschueren-Lodeweyckx M. Age and
height at diagnosis in Turner syndrome: influence of
parental height. Pediatrics. 1991; 88: 1148-52.
20. Moreno-García, M, Martínez, FJF, Miranda EB.
Chromosomal anomalies in patients with short stature.
Pediatr Interl. 2005; 47: 546-9.
21. Lemos-Marini SH, Morcillo AM, Baptista MT, Guerra-Jr
G, Maciel-Guerra AT. Spontaneous final height in Turner's
syndrome in Brazil. J Pediatr Endocrinol Metab. 2007; 20:
1207-14.
22. Román R, Vallejos ME, Muñoz M, Schneider R, Youlton R,
Henriquez C, Cassorla F. Turner's syndrome: growth and
clinical description of 83 Chilean girls. Rev Med Chil.
2002; 130: 977-84.
23. Soriano-Guillén L, Coste J, Ecosse E, Léger J, Tauber M,
Cabrol S, Nicolino M, Brauner R, Chaussain JL, Carel JC.
Adult height and pubertal growth in Turner syndrome after
treatment with recombinant growth hormone J Clin
Endocrinolo Metab. 2005; 90: 5197-204.
24. Ramos AV, Silva IN, Goulart EMA. Turner syndrome:
searching for better outcomes. Clinics. 2008; 63: 173-8.
25. Isojima T, Yokoya S, Ito J, Horikawa R, Tanaka T. Trends
in Age and Anthropometric Data at Start of Growth
Hormone Treatment for Girls with Turner Syndrome in
Japan. [Accessed 26 out 2008]. Available in:
http://www.jstage.jst.go.jp/ article/endocrj/ advpub/0/
advpub_ 0808250186/_article
26. Bondy CA. Care of girls and women with Turner syndrome:
a guideline of the Turner syndrome study group. J Clin
Endocrinol Metab. 2007; 92: 10-25.
27. Betts PR, Butler GE, Donaldson MDC, Dunger DB,
Johnston DI, Kelnar CJH, Krik J, Price DA, Wilton P. A
decade of growth hormone treatment in girls with Turner
syndrome in the UK. UK KIGS Executive Group. Arch Dis
Child. 1999; 80: 221-5.
28. Rongen-Westerlaken C, Corel L, Van den Broeck J, Massa
G, Kalberg J, Albertsson-Wikland,K Naeraa RW, Wit JM.
Reference values for height, height velocity and weight in
Turner's syndrome. Acta Paediatr. 1997; 86: 937-42.
29. Davenport ML, Punyasavatsut N, Stewart PW, Gunther DF,
Sävendahl L, Sybert VP. Growth failure in early life: An
important manifestation of Turner Syndrome. Horm Res.
2002; 57: 157-64. | pt_BR |